Free Trial

Syros Pharmaceuticals (SYRS) Short Interest Ratio & Short Volume

Syros Pharmaceuticals logo
$2.26
-0.26 (-10.32%)
(As of 03:31 PM ET)

Syros Pharmaceuticals Short Interest Data

Syros Pharmaceuticals (SYRS) has a short interest of 952,600 shares, representing 4.82% of the float (the number of shares available for trading by the public). This marks a -4.73% decrease in short interest from the previous month. The short interest ratio (days to cover) is 2.5, indicating that it would take 2.5 days of the average trading volume of 242,114 shares to cover all short positions.

Current Short Interest
952,600 shares
Previous Short Interest
999,900 shares
Change Vs. Previous Month
-4.73%
Dollar Volume Sold Short
$1.90 million
Short Interest Ratio
2.5 Days to Cover
Last Record Date
October 15, 2024
Outstanding Shares
26,810,000 shares
Float Size
19,760,000 shares
Short Percent of Float
4.82%
Today's Trading Volume
362,857 shares
Average Trading Volume
242,114 shares
Today's Volume Vs. Average
150%
Short Selling Syros Pharmaceuticals?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Syros Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

SYRS Short Interest Over Time

SYRS Days to Cover Over Time

SYRS Percentage of Float Shorted Over Time

Syros Pharmaceuticals Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
10/15/2024952,600 shares $1.90 million -4.7%4.8%2.5 $1.99
9/30/2024999,900 shares $2.15 million -9.1%5.1%3.1 $2.15
9/15/20241,100,000 shares $2.15 million +14.9%5.6%3.6 $1.95
8/31/2024957,500 shares $1.57 million -22.8%4.8%4 $1.64
8/15/20241,240,000 shares $1.90 million -6.8%6.2%5.3 $1.53
7/31/20241,330,000 shares $7.98 million +4.7%6.7%12.9 $6.00
7/15/20241,270,000 shares $7.80 million -3.1%6.4%12.5 $6.14
6/30/20241,310,000 shares $6.76 million +4.0%6.6%9.8 $5.16
6/15/20241,260,000 shares $7.56 million -4.6%6.4%7.8 $6.00
5/31/20241,320,000 shares $6.73 million -13.2%6.6%8 $5.10
5/15/20241,520,000 shares $8.38 million +4.8%7.6%8 $5.51
4/30/20241,450,000 shares $7.83 million -22.0%7.8%7.4 $5.40
4/15/20241,860,000 shares $9.95 million +2.2%10.1%8.5 $5.35
3/31/20241,820,000 shares $9.74 million +4.6%9.9%8.4 $5.35
3/15/20241,740,000 shares $10.46 million +31.8%9.6%8.2 $6.01
2/29/20241,320,000 shares $9.58 million +29.4%7.3%4.1 $7.26
2/15/20241,020,000 shares $7.22 million +38.1%5.6%3.4 $7.08
1/31/2024738,800 shares $5.28 million +27.1%3.6%2.6 $7.14
1/15/2024581,200 shares $4.21 million +18.5%2.8%2.2 $7.24
12/31/2023490,600 shares $3.82 million -2.6%2.5%2.1 $7.79
12/15/2023503,500 shares $2.09 million +2.1%2.5%2.5 $4.16
11/30/2023493,400 shares $1.36 million +0.3%3.0%3.2 $2.75
11/15/2023491,800 shares $1.50 million -11.1%3.0%8.5 $3.04
10/31/2023553,100 shares $1.38 million -9.5%3.4%9.3 $2.49
10/15/2023611,200 shares $1.58 million -5.6%3.8%10.5 $2.59
9/30/2023647,300 shares $2.56 million +8.7%4.0%10.7 $3.95
9/15/2023595,500 shares $2.34 million -4.2%3.7%9.7 $3.93
8/31/2023621,800 shares $2.43 million -0.1%3.8%9.9 $3.90
8/15/2023622,600 shares $2.37 million -6.4%3.8%9.3 $3.81
7/31/2023665,000 shares $2.65 million +0.8%3.6%9 $3.98
7/15/2023660,000 shares $2.21 million +2.9%3.6%8.5 $3.35
6/30/2023641,500 shares $2.02 million +1.9%3.5%8.2 $3.15
6/15/2023629,700 shares $2.04 million +0.6%3.5%7.7 $3.24
5/31/2023625,800 shares $2.41 million -0.7%4.0%6.2 $3.85
5/15/2023630,200 shares $2.37 million -4.9%4.0%5.8 $3.76
4/30/2023662,700 shares $2.11 million -6.2%4.4%6.3 $3.18
4/15/2023706,700 shares $1.91 million -2.4%4.7%5.5 $2.70
3/31/2023724,200 shares $1.93 million +11.5%4.8%5.5 $2.67
3/15/2023649,500 shares $2.01 million +21.6%4.3%4.9 $3.09
2/28/2023534,300 shares $2.01 million -5.9%3.6%4.4 $3.76
Charles Payne Wants You Prepared for Q4 (Ad)

Charles Payne Wants You Prepared for Q4 Because as we look toward 2025, there's no denying that market volatility, inflation, and recession fears are top of mind for every investor Now more than ever, it's crucial to have a solid plan for navigating uncertainty and coming out ahead.

Click here to secure your seat now.
2/15/2023567,600 shares $2.35 million -7.7%3.8%4.8 $4.14
1/31/2023615,100 shares $3.14 million +5.2%3.8%4.9 $5.11
1/15/2023584,700 shares $2.79 million -39.4%3.7%5.4 $4.77
12/30/2022964,400 shares $3.46 million +1.9%6.0%8.3 $3.59
12/15/2022946,500 shares $3.43 million +13.2%5.9%7.6 $3.62
11/30/2022836,400 shares $3.31 million +1.6%5.2%3.3 $3.96
11/15/2022823,300 shares $3.30 million +21.8%5.1%3.4 $4.01
10/31/2022676,000 shares $3.39 million +11.1%3.4%2.9 $5.02
10/15/2022608,700 shares $3.51 million -13.7%3.1%2.6 $5.77
9/30/2022705,200 shares $4.54 million -9.1%8.9%3.2 $6.44
9/15/2022775,700 shares $5.66 million -79.9%12.6%3.6 $7.29
8/31/20223,850,000 shares $3.08 million +5.2%14.3%5.3 $0.80
8/15/20223,660,000 shares $3.70 million +78.5%13.6%4.5 $1.01
7/31/20222,050,000 shares $1.61 million No Change7.6%2.4 $0.79
7/15/20222,050,000 shares $1.92 million +31.4%7.6%2.4 $0.94
6/30/20221,560,000 shares $1.50 million -53.3%3.5%1.7 $0.96
6/15/20223,340,000 shares $3.57 million -4.8%7.5%3.3 $1.07
5/31/20223,510,000 shares $2.89 million -14.8%8.0%3.9 $0.82
5/15/20224,120,000 shares $3.70 million +9.6%9.4%5 $0.90
4/30/20223,760,000 shares $3.17 million +29.7%9.0%4.9 $0.84
4/15/20222,900,000 shares $2.63 million -9.4%7.0%3.9 $0.91
3/31/20223,200,000 shares $3.81 million -4.8%7.8%5.4 $1.19
3/15/20223,360,000 shares $3.73 million -18.8%8.2%7 $1.11
2/28/20224,140,000 shares $5.34 million +1.7%10.1%9.3 $1.29
2/15/20224,070,000 shares $6.47 million -4.7%9.9%9.4 $1.59
1/31/20224,270,000 shares $8.45 million +4.4%10.9%10 $1.98
1/15/20224,090,000 shares $11.00 million +19.6%10.5%11.6 $2.69
12/31/20213,420,000 shares $11.15 million No Change8.8%10.2 $3.26
12/15/20213,420,000 shares $11.97 million -7.6%8.8%9.4 $3.50
11/30/20213,700,000 shares $14.65 million +3.6%9.5%8.2 $3.96
11/15/20213,570,000 shares $15.21 million -7.0%9.2%7.6 $4.26
10/29/20213,840,000 shares $15.86 million -6.8%9.8%8.1 $4.13
10/15/20214,120,000 shares $18.66 million +1.7%10.5%8.1 $4.53
9/30/20214,050,000 shares $18.10 million -6.0%10.3%7 $4.47
9/15/20214,310,000 shares $22.58 million -2.9%11.0%6.5 $5.24
8/31/20214,440,000 shares $23.53 million No Change11.3%6 $5.30
8/13/20214,440,000 shares $20.34 million +2.1%11.3%3.6 $4.58
7/30/20214,350,000 shares $20.10 million +9.9%10.8%3.2 $4.62
7/15/20213,960,000 shares $18.14 million -17.2%9.4%2.9 $4.58
6/30/20214,780,000 shares $26.05 million -2.3%11.4%3.5 $5.45
6/15/20214,890,000 shares $28.07 million -14.4%11.7%3.6 $5.74
5/28/20215,710,000 shares $36.83 million -6.6%13.7%4.6 $6.45
5/14/20216,110,000 shares $31.10 million +15.7%14.6%6.8 $5.09
4/30/20215,280,000 shares $32.95 million +7.8%12.5%7.4 $6.24
4/15/20214,900,000 shares $32.49 million -9.4%11.6%6.9 $6.63
3/31/20215,410,000 shares $39.20 million +10.9%12.8%7.1 $7.25
3/15/20214,880,000 shares $43.82 million +21.1%11.6%6.2 $8.98
2/26/20214,030,000 shares $35.79 million +10.7%9.6%5 $8.88
2/12/20213,640,000 shares $42.77 million -4.0%8.7%4.9 $11.75
1/29/20213,790,000 shares $40.36 million +7.7%N/A5.4 $10.65
The most serious warning of my career (Ad)

With the 2024 election just weeks away, a new crisis is barrelling down on America… one that could cleave the financial world in two the moment the polls close. I predict they could see investment losses of 50% (or more) in the weeks following the presidential election.

Click here now to grab your seat now.
1/15/20213,520,000 shares $48.68 million No ChangeN/A4.9 $13.83
12/31/20203,520,000 shares $41.78 million -22.8%8.8%5.6 $11.87
12/15/20204,560,000 shares $53.12 million +2.0%14.0%7.8 $11.65
11/30/20204,470,000 shares $36.43 million -3.7%11.3%8.8 $8.15
11/15/20204,640,000 shares $40.74 million -20.6%11.7%10 $8.78
10/30/20205,840,000 shares $40.18 million +4.1%14.7%12 $6.88
10/15/20205,610,000 shares $50.01 million +15.7%14.2%13.5 $8.92
9/30/20204,850,000 shares $42.87 million +31.1%12.2%13 $8.84
9/15/20203,700,000 shares $38.48 million +2.2%9.3%9.9 $10.40
8/31/20203,620,000 shares $47.97 million +31.2%9.1%9.9 $13.25
8/14/20202,760,000 shares $32.87 million -4.8%7.0%7.9 $11.91
7/31/20202,900,000 shares $27.52 million -1.4%8.2%9 $9.49
7/15/20202,940,000 shares $33.49 million -7.8%8.4%8.2 $11.39
6/30/20203,190,000 shares $34.01 million +13.9%9.1%8.5 $10.66
6/15/20202,800,000 shares $25.82 million -1.8%8.0%7.9 $9.22
5/29/20202,850,000 shares $27.90 million +2.5%8.2%9 $9.79
5/15/20202,780,000 shares $26.22 million +2.6%8.0%8.5 $9.43
4/30/20202,710,000 shares $22.93 million -4.2%7.9%9.6 $8.46
4/15/20202,830,000 shares $24.65 million +19.4%8.8%11.4 $8.71
3/31/20202,370,000 shares $19.22 million -5.3%7.4%9.3 $8.11
3/13/20202,502,900 shares $18.67 million +7.9%11.6%7.1 $7.46
2/28/20202,320,000 shares $13.32 million -4.9%10.8%5.5 $5.74
2/14/20202,440,000 shares $12.91 million -2.0%7.8%6.2 $5.29
1/31/20202,490,000 shares $16.04 million No Change8.0%5.9 $6.44
1/15/20202,490,000 shares $19.32 million +6.4%8.1%5.4 $7.76
12/31/20192,340,000 shares $16.94 million +30.0%7.6%4.9 $7.24

SYRS Short Interest - Frequently Asked Questions

What is Syros Pharmaceuticals' current short interest?

Short interest is the volume of Syros Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of October 15th, investors have sold 952,600 shares of SYRS short. 4.82% of Syros Pharmaceuticals' shares are currently sold short. Learn More on Syros Pharmaceuticals' current short interest.

What is a good short interest ratio for Syros Pharmaceuticals?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. SYRS shares currently have a short interest ratio of 2.0. Learn More on Syros Pharmaceuticals's short interest ratio.

What is a good short interest percentage for Syros Pharmaceuticals?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 4.82% of Syros Pharmaceuticals' floating shares are currently sold short.

Is Syros Pharmaceuticals' short interest increasing or decreasing?

Syros Pharmaceuticals saw a drop in short interest in the month of October. As of October 15th, there was short interest totaling 952,600 shares, a drop of 4.7% from the previous total of 999,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Syros Pharmaceuticals' float size?

Syros Pharmaceuticals currently has issued a total of 26,810,000 shares. Some of Syros Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Syros Pharmaceuticals currently has a public float of 19,760,000 shares.

How does Syros Pharmaceuticals' short interest compare to its competitors?

4.82% of Syros Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies compare to Syros Pharmaceuticals: Cue Biopharma, Inc. (4.01%), Eton Pharmaceuticals, Inc. (0.84%), Gossamer Bio, Inc. (3.07%), Instil Bio, Inc. (26.37%), Zentalis Pharmaceuticals, Inc. (10.77%), Fulcrum Therapeutics, Inc. (8.85%), Galecto, Inc. (0.90%), Organigram Holdings Inc. (3.30%), Atai Life Sciences (8.19%), Cabaletta Bio, Inc. (7.74%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.14 billion), AppLovin Co. ($3.15 billion), Paychex, Inc. ($2.69 billion), Nu Holdings Ltd. ($2.48 billion), Cencora, Inc. ($2.24 billion), International Paper ($2.04 billion), Tractor Supply ($1.96 billion), Coinbase Global, Inc. ($1.93 billion), Moderna, Inc. ($1.91 billion), and SoFi Technologies, Inc. ($1.84 billion). View all of the most shorted stocks.

What does it mean to sell short Syros Pharmaceuticals stock?

Short selling SYRS is an investing strategy that aims to generate trading profit from Syros Pharmaceuticals as its price is falling. SYRS shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Syros Pharmaceuticals?

A short squeeze for Syros Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of SYRS, which in turn drives the price of the stock up even further.

How often is Syros Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SYRS, twice per month. The most recent reporting period available is October, 15 2024.




This page (NASDAQ:SYRS) was last updated on 11/1/2024 by MarketBeat.com Staff
From Our Partners